180(top 1%)
PR articles
53.0K(top 0.1%)
PR citations
106(top 0.1%)
PR h-index
116(top 0.1%)
h-index
203
documents
72.3K
doc citations
3.9K
citing journals
100
times ranked

Publications

180 peer-reviewed articles • 57,098 peer-reviewed citations • Sorted by year • Download PDF (PDF by citations)
Sort: Year | Citations
#ArticleIFCitationsLinks
1Nanoparticle protein corona evolution: from biological impact to biomarker discovery
Nanoscale, 2022, 14, 1606-1620
3.656Citations (PDF)
2Enhanced Competition at the Nano–Bio Interface Enables Comprehensive Characterization of Protein Corona Dynamics and Deep Coverage of Proteomes
Advanced Materials, 2022, 34,
17.562Citations (PDF)
3Analysis of the Human Plasma Proteome Using Multi‐Nanoparticle Protein Corona for Detection of Alzheimer's Disease
Advanced Healthcare Materials, 2021, 10,
6.649Citations (PDF)
4Adjuvant-pulsed mRNA vaccine nanoparticle for immunoprophylactic and therapeutic tumor suppression in mice
Biomaterials, 2021, 266, 120431
9.5204Citations (PDF)
5Nano–Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection
Accounts of Chemical Research, 2021, 54, 291-301
11.6151Citations (PDF)
6Stanene‐Based Nanosheets for β‐Elemene Delivery and Ultrasound‐Mediated Combination Cancer Therapy
Angewandte Chemie, 2021, 133, 7231-7240
0.912Citations (PDF)
7Stanene‐Based Nanosheets for β‐Elemene Delivery and Ultrasound‐Mediated Combination Cancer Therapy
Angewandte Chemie - International Edition, 2021, 60, 7155-7164
11.6184Citations (PDF)
8Targeted delivery of protein arginine deiminase-4 inhibitors to limit arterial intimal NETosis and preserve endothelial integrity
Cardiovascular Research, 2021, ,
5.756Citations (PDF)
9Reactivation of the tumor suppressor PTEN by mRNA nanoparticles enhances antitumor immunity in preclinical models
Science Translational Medicine, 2021, 13,
8.7227Citations (PDF)
10Redox-responsive polyprodrug nanoparticles for targeted siRNA delivery and synergistic liver cancer therapy
Biomaterials, 2020, 234, 119760
9.5125Citations (PDF)
11A materials-science perspective on tackling COVID-19
Nature Reviews Materials, 2020, 5, 847-860
56.8295Citations (PDF)
12Oral Insulin Delivery Platforms: Strategies To Address the Biological Barriers
Angewandte Chemie - International Edition, 2020, 59, 19787-19795
11.6154Citations (PDF)
13siRNA nanoparticles targeting CaMKIIγ in lesional macrophages improve atherosclerotic plaque stability in mice
Science Translational Medicine, 2020, 12,
8.7242Citations (PDF)
14Rücktitelbild: Plattformen für die orale Insulinabgabe: Strategien zur Beseitigung der biologischen Barrieren (Angew. Chem. 45/2020)
Angewandte Chemie, 2020, 132, 20424-20424
0.91Citations (PDF)
15Plattformen für die orale Insulinabgabe: Strategien zur Beseitigung der biologischen Barrieren
Angewandte Chemie, 2020, 132, 19955-19964
0.95Citations (PDF)
16Dual Hypoxia-Targeting RNAi Nanomedicine for Precision Cancer Therapy
Nano Letters, 2020, 20, 4857-4863
6.262Citations (PDF)
17Germanene-Based Theranostic Materials for Surgical Adjuvant Treatment: Inhibiting Tumor Recurrence and Wound Infection
Matter, 2020, 3, 127-144
9.6248Citations (PDF)
18Marriage of black phosphorus and Cu2+ as effective photothermal agents for PET-guided combination cancer therapy
Nature Communications, 2020, 11,
10.8331Citations (PDF)
19Nanostructure Engineering by Simple Tuning of Lipid Combinations
Angewandte Chemie, 2020, 132, 6308-6311
0.92Citations (PDF)
20ROS-Mediated Selective Killing Effect of Black Phosphorus: Mechanistic Understanding and Its Guidance for Safe Biomedical Applications
Nano Letters, 2020, 20, 3943-3955
6.2208Citations (PDF)
21Phosphorus Science-Oriented Design and Synthesis of Multifunctional Nanomaterials for Biomedical Applications
Matter, 2020, 2, 297-322
9.6195Citations (PDF)
22Nanostructure Engineering by Simple Tuning of Lipid Combinations
Angewandte Chemie - International Edition, 2020, 59, 6249-6252
11.624Citations (PDF)
23Charge Conversional Biomimetic Nanocomplexes as a Multifunctional Platform for Boosting Orthotopic Glioblastoma RNAi Therapy
Nano Letters, 2020, 20, 1637-1646
6.2158Citations (PDF)
24Sugar-Nanocapsules Imprinted with Microbial Molecular Patterns for mRNA Vaccination
Nano Letters, 2020, 20, 1499-1509
6.289Citations (PDF)
25Stimuli-Responsive Polymer–Prodrug Hybrid Nanoplatform for Multistage siRNA Delivery and Combination Cancer Therapy
Nano Letters, 2019, 19, 5967-5974
6.2134Citations (PDF)
262D Monoelemental Germanene Quantum Dots: Synthesis as Robust Photothermal Agents for Photonic Cancer Nanomedicine
Angewandte Chemie, 2019, 131, 13539-13544
0.949Citations (PDF)
272D Monoelemental Germanene Quantum Dots: Synthesis as Robust Photothermal Agents for Photonic Cancer Nanomedicine
Angewandte Chemie - International Edition, 2019, 58, 13405-13410
11.6119Citations (PDF)
28Emerging two-dimensional monoelemental materials (Xenes) for biomedical applications
Chemical Society Reviews, 2019, 48, 2891-2912
32.1605Citations (PDF)
29Synthetic mRNA nanoparticle-mediated restoration of p53 tumor suppressor sensitizes p53 -deficient cancers to mTOR inhibition
Science Translational Medicine, 2019, 11,
8.7304Citations (PDF)
30Glutathione-Responsive Prodrug Nanoparticles for Effective Drug Delivery and Cancer Therapy
ACS Nano, 2019, 13, 357-370
11.5264Citations (PDF)
31Drug loading augmentation in polymeric nanoparticles using a coaxial turbulent jet mixer: Yong investigator perspective
Journal of Colloid and Interface Science, 2019, 538, 45-50
7.922Citations (PDF)
32Nanotechnology-Based Strategies for siRNA Brain Delivery for Disease Therapy
Trends in Biotechnology, 2018, 36, 562-575
6.6209Citations (PDF)
33Intracellular Mechanistic Understanding of 2D MoS2 Nanosheets for Anti-Exocytosis-Enhanced Synergistic Cancer Therapy
ACS Nano, 2018, 12, 2922-2938
11.5220Citations (PDF)
34Engineering of Mature Human Induced Pluripotent Stem Cell‐Derived Cardiomyocytes Using Substrates with Multiscale Topography
Advanced Functional Materials, 2018, 28,
11.950Citations (PDF)
35Nanoparticles targeting extra domain B of fibronectin-specific to the atherosclerotic lesion types III, IV, and V-enhance plaque detection and cargo delivery
Theranostics, 2018, 8, 6008-6024
8.124Citations (PDF)
36Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA
Nature Biomedical Engineering, 2018, 2, 850-864
14.4317Citations (PDF)
37Redox‐Responsive Nanoparticle‐Mediated Systemic RNAi for Effective Cancer Therapy
Small, 2018, 14,
7.3103Citations (PDF)
38Two‐Dimensional Antimonene‐Based Photonic Nanomedicine for Cancer Theranostics
Advanced Materials, 2018, 30,
17.5343Citations (PDF)
39Flat Cell Culturing Surface May Cause Misinterpretation of Cellular Uptake of Nanoparticles
Advanced Biology, 2018, 2,
3.47Citations (PDF)
40Glutathione-Scavenging Poly(disulfide amide) Nanoparticles for the Effective Delivery of Pt(IV) Prodrugs and Reversal of Cisplatin Resistance
Nano Letters, 2018, 18, 4618-4625
6.2200Citations (PDF)
41Personalized protein corona on nanoparticles and its clinical implications
Biomaterials Science, 2017, 5, 378-387
4.0289Citations (PDF)
42Hyper-cell-permeable micelles as a drug delivery carrier for effective cancer therapy
Biomaterials, 2017, 123, 118-126
9.544Citations (PDF)
43Multifunctional Envelope-Type siRNA Delivery Nanoparticle Platform for Prostate Cancer Therapy
ACS Nano, 2017, 11, 2618-2627
11.5197Citations (PDF)
44Antimonene Quantum Dots: Synthesis and Application as Near‐Infrared Photothermal Agents for Effective Cancer Therapy
Angewandte Chemie - International Edition, 2017, 56, 11896-11900
11.6511Citations (PDF)
45Tumor Microenvironment-Responsive Multistaged Nanoplatform for Systemic RNAi and Cancer Therapy
Nano Letters, 2017, 17, 4427-4435
6.2129Citations (PDF)
46Antimonene Quantum Dots: Synthesis and Application as Near‐Infrared Photothermal Agents for Effective Cancer Therapy
Angewandte Chemie, 2017, 129, 12058-12062
0.9103Citations (PDF)
47Design of Insulin-Loaded Nanoparticles Enabled by Multistep Control of Nanoprecipitation and Zinc Chelation
ACS Applied Materials & Interfaces, 2017, 9, 11440-11450
5.534Citations (PDF)
48Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics
Nature Communications, 2017, 8,
10.8672Citations (PDF)
49Nanomedicine for safe healing of bone trauma: Opportunities and challenges
Biomaterials, 2017, 146, 168-182
9.578Citations (PDF)
50Multiscale technologies for treatment of ischemic cardiomyopathy
Nature Nanotechnology, 2017, 12, 845-855
23.4138Citations (PDF)
51Targeted Nanotherapeutics Encapsulating Liver X Receptor Agonist GW3965 Enhance Antiatherogenic Effects without Adverse Effects on Hepatic Lipid Metabolism in Ldlr−/− Mice
Advanced Healthcare Materials, 2017, 6,
6.680Citations (PDF)
52ROS‐Responsive Polyprodrug Nanoparticles for Triggered Drug Delivery and Effective Cancer Therapy
Advanced Materials, 2017, 29,
17.5480Citations (PDF)
53Cellular uptake of nanoparticles: journey inside the cell
Chemical Society Reviews, 2017, 46, 4218-4244
32.12,667Citations (PDF)
54Evolution of macromolecular complexity in drug delivery systems
Nature Reviews Chemistry, 2017, 1,
29.4307Citations (PDF)
55Innentitelbild: Antimonene Quantum Dots: Synthesis and Application as Near‐Infrared Photothermal Agents for Effective Cancer Therapy (Angew. Chem. 39/2017)
Angewandte Chemie, 2017, 129, 11816-11816
0.92Citations (PDF)
56Challenges in DNA Delivery and Recent Advances in Multifunctional Polymeric DNA Delivery Systems
Biomacromolecules, 2017, 18, 2231-2246
3.8191Citations (PDF)
57A drug-delivery strategy for overcoming drug resistance in breast cancer through targeting of oncofetal fibronectin
Nanomedicine: Nanotechnology, Biology, and Medicine, 2017, 13, 713-722
2.341Citations (PDF)
58Biological Identity of Nanoparticles In Vivo : Clinical Implications of the Protein Corona
Trends in Biotechnology, 2017, 35, 257-264
6.6398Citations (PDF)
59Emerging Advances in Nanotheranostics with Intelligent Bioresponsive Systems
Theranostics, 2017, 7, 3915-3919
8.152Citations (PDF)
60Surface De-PEGylation Controls Nanoparticle-Mediated siRNA Delivery In Vitro and In Vivo
Theranostics, 2017, 7, 1990-2002
8.1135Citations (PDF)
61Polymeric Nanoparticles Amenable to Simultaneous Installation of Exterior Targeting and Interior Therapeutic Proteins
Angewandte Chemie - International Edition, 2016, 55, 3309-3312
11.6145Citations (PDF)
62Ultra‐pH‐Responsive and Tumor‐Penetrating Nanoplatform for Targeted siRNA Delivery with Robust Anti‐Cancer Efficacy
Angewandte Chemie - International Edition, 2016, 55, 7091-7094
11.6245Citations (PDF)
63Preventing diet-induced obesity in mice by adipose tissue transformation and angiogenesis using targeted nanoparticles
Proceedings of the National Academy of Sciences of the United States of America, 2016, 113, 5552-5557
5.2181Citations (PDF)
64Targeted Interleukin-10 Nanotherapeutics Developed with a Microfluidic Chip Enhance Resolution of Inflammation in Advanced Atherosclerosis
ACS Nano, 2016, 10, 5280-5292
11.5214Citations (PDF)
65Targeted Nanoparticles for Colorectal Cancer
Nanomedicine, 2016, 11, 2443-2456
2.5152Citations (PDF)
66Emerging understanding of the protein corona at the nano-bio interfaces
Nano Today, 2016, 11, 817-832
7.3238Citations (PDF)
67Nanomedicines for renal disease: current status and future applications
Nature Reviews Nephrology, 2016, 12, 738-753
24.3240Citations (PDF)
68Ultra‐pH‐Responsive and Tumor‐Penetrating Nanoplatform for Targeted siRNA Delivery with Robust Anti‐Cancer Efficacy
Angewandte Chemie, 2016, 128, 7207-7210
0.910Citations (PDF)
69Theranostic near-infrared fluorescent nanoplatform for imaging and systemic siRNA delivery to metastatic anaplastic thyroid cancer
Proceedings of the National Academy of Sciences of the United States of America, 2016, 113, 7750-7755
5.289Citations (PDF)
70Polymeric Nanoparticles Amenable to Simultaneous Installation of Exterior Targeting and Interior Therapeutic Proteins
Angewandte Chemie, 2016, 128, 3370-3373
0.911Citations (PDF)
71Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
Chemical Reviews, 2016, 116, 2602-2663
42.52,903Citations (PDF)
72Nanotechnology for protein delivery: Overview and perspectives
Journal of Controlled Release, 2016, 240, 24-37
8.1385Citations (PDF)
73Cancer nanomedicine: progress, challenges and opportunities
Nature Reviews Cancer, 2016, 17, 20-37
34.55,526Citations (PDF)
74Hydrophobic Cysteine Poly(disulfide)‐based Redox‐Hypersensitive Nanoparticle Platform for Cancer Theranostics
Angewandte Chemie, 2015, 127, 9350-9355
0.940Citations (PDF)
75Hydrophobic Cysteine Poly(disulfide)‐based Redox‐Hypersensitive Nanoparticle Platform for Cancer Theranostics
Angewandte Chemie - International Edition, 2015, 54, 9218-9223
11.6183Citations (PDF)
76Drug Delivery Nanocarriers from a Fully Degradable PEG‐Conjugated Polyester with a Reduction‐Responsive Backbone
Chemistry - A European Journal, 2015, 21, 11325-11329
2.426Citations (PDF)
77Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice
Science Translational Medicine, 2015, 7,
8.7331Citations (PDF)
78Effect of PEG Pairing on the Efficiency of Cancer-Targeting Liposomes
Theranostics, 2015, 5, 746-754
8.176Citations (PDF)
79Nanomedicines for endothelial disorders
Nano Today, 2015, 10, 759-776
7.355Citations (PDF)
80Cancer nanomedicine: from targeted delivery to combination therapy
Trends in Molecular Medicine, 2015, 21, 223-232
6.4672Citations (PDF)
81Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance
Proceedings of the National Academy of Sciences of the United States of America, 2015, 112,
5.2437Citations (PDF)
82Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment
Proceedings of the National Academy of Sciences of the United States of America, 2015, 112, 7779-7784
5.2199Citations (PDF)
83A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells
Science, 2015, 348,
26.1373Citations (PDF)
84Polymeric nanoparticle drug delivery technologies for oral delivery applications
Expert Opinion on Drug Delivery, 2015, 12, 1459-1473
3.7253Citations (PDF)
85Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug
Nature Communications, 2015, 6,
10.8418Citations (PDF)
86Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle
Science Translational Medicine, 2015, 7,
8.7325Citations (PDF)
87Nanoparticles Containing a Liver X Receptor Agonist Inhibit Inflammation and Atherosclerosis
Advanced Healthcare Materials, 2015, 4, 228-236
6.679Citations (PDF)
88Annexin A1–containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair
Journal of Clinical Investigation, 2015, 125, 1215-1227
6.6327Citations (PDF)
89Development of Therapeutic Polymeric Nanoparticles for the Resolution of Inflammation
Advanced Healthcare Materials, 2014, 3, 1448-1456
6.634Citations (PDF)
90Ultra-High Throughput Synthesis of Nanoparticles with Homogeneous Size Distribution Using a Coaxial Turbulent Jet Mixer
ACS Nano, 2014, 8, 6056-6065
11.5285Citations (PDF)
91Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
Advanced Drug Delivery Reviews, 2014, 66, 2-25
12.52,707Citations (PDF)
92Development of Multinuclear Polymeric Nanoparticles as Robust Protein Nanocarriers
Angewandte Chemie, 2014, 126, 9121-9125
0.910Citations (PDF)
93A Solvent-Free Thermosponge Nanoparticle Platform for Efficient Delivery of Labile Proteins
Nano Letters, 2014, 14, 6449-6455
6.243Citations (PDF)
94Development of Multinuclear Polymeric Nanoparticles as Robust Protein Nanocarriers
Angewandte Chemie - International Edition, 2014, 53, 8975-8979
11.6140Citations (PDF)
95Current Progress of Aptamer-Based Molecular Imaging
Journal of Nuclear Medicine, 2014, 55, 353-356
3.9103Citations (PDF)
96Insight into nanoparticle cellular uptake and intracellular targeting
Journal of Controlled Release, 2014, 190, 485-499
8.1753Citations (PDF)
97Polymeric Nanoparticle Technologies for Oral Drug Delivery
Clinical Gastroenterology and Hepatology, 2014, 12, 1605-1610
5.0161Citations (PDF)
98Engineered nanomedicine for myeloma and bone microenvironment targeting
Proceedings of the National Academy of Sciences of the United States of America, 2014, 111, 10287-10292
5.2271Citations (PDF)
99Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release
Vaccine, 2014, 32, 2882-2895
2.0166Citations (PDF)
100Parallel microfluidic synthesis of size-tunable polymeric nanoparticles using 3D flow focusing towards in vivo study
Nanomedicine: Nanotechnology, Biology, and Medicine, 2014, 10, 401-409
2.3157Citations (PDF)
101Hybrid lipid–polymer nanoparticles for sustained siRNA delivery and gene silencing
Nanomedicine: Nanotechnology, Biology, and Medicine, 2014, 10, e897-e900
2.393Citations (PDF)
102Synthesis and in vitro evaluation of a multifunctional and surface-switchable nanoemulsion platform
Chemical Communications, 2013, 49, 9392
2.416Citations (PDF)
103Synthesis of Polymer–Lipid Nanoparticles for Image-Guided Delivery of Dual Modality Therapy
Bioconjugate Chemistry, 2013, 24, 1429-1434
2.9111Citations (PDF)
104Single Step Reconstitution of Multifunctional High-Density Lipoprotein-Derived Nanomaterials Using Microfluidics
ACS Nano, 2013, 7, 9975-9983
11.5117Citations (PDF)
105Enhancing tumor cell response to chemotherapy through nanoparticle-mediated codelivery of siRNA and cisplatin prodrug
Proceedings of the National Academy of Sciences of the United States of America, 2013, 110, 18638-18643
5.2336Citations (PDF)
106Transepithelial Transport of Fc-Targeted Nanoparticles by the Neonatal Fc Receptor for Oral Delivery
Science Translational Medicine, 2013, 5,
8.7379Citations (PDF)
107HER2-specific aptide conjugated magneto-nanoclusters for potential breast cancer imaging and therapy
Journal of Materials Chemistry B, 2013, 1, 4576
4.317Citations (PDF)
108Synergistic Cytotoxicity of Irinotecan and Cisplatin in Dual-Drug Targeted Polymeric Nanoparticles
Nanomedicine, 2013, 8, 687-698
2.571Citations (PDF)
109Nanoparticle Encapsulation of Mitaplatin and the Effect Thereof onIn VivoProperties
ACS Nano, 2013, 7, 5675-5683
11.591Citations (PDF)
110Microfluidic Platform for Combinatorial Synthesis and Optimization of Targeted Nanoparticles for Cancer Therapy
ACS Nano, 2013, 7, 10671-10680
11.5225Citations (PDF)
111Spontaneous Formation of Heterogeneous Patches on Polymer–Lipid Core–Shell Particle Surfaces during Self‐Assembly
Small, 2013, 9, 511-517
7.318Citations (PDF)
112Nanoparticle Design For Bone-Specific Chemotherapy and Microenvironmental Targeting In Multiple Myeloma
Blood, 2013, 122, 881-881
3.62Citations (PDF)
113Nanoparticle-Aptamer Bioconjugates for Targeted Antineoplastic Drug Delivery
American Journal of Drug Delivery, 2012, 4, 123-130
0.82Citations (PDF)
114Surface Charge-Switching Polymeric Nanoparticles for Bacterial Cell Wall-Targeted Delivery of Antibiotics
ACS Nano, 2012, 6, 4279-4287
11.5522Citations (PDF)
115Bioinspired multivalent DNA network for capture and release of cells
Proceedings of the National Academy of Sciences of the United States of America, 2012, 109, 19626-19631
5.2284Citations (PDF)
116Engineering of Targeted Nanoparticles for Cancer Therapy Using Internalizing Aptamers Isolated by Cell-Uptake Selection
ACS Nano, 2012, 6, 696-704
11.5153Citations (PDF)
117Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine
Advanced Drug Delivery Reviews, 2012, 64, 1363-1384
12.5469Citations (PDF)
118DNA Self‐Assembly of Targeted Near‐Infrared‐Responsive Gold Nanoparticles for Cancer Thermo‐Chemotherapy
Angewandte Chemie, 2012, 124, 12023-12027
0.992Citations (PDF)
119DNA Self‐Assembly of Targeted Near‐Infrared‐Responsive Gold Nanoparticles for Cancer Thermo‐Chemotherapy
Angewandte Chemie - International Edition, 2012, 51, 11853-11857
11.6325Citations (PDF)
120Microfluidic technologies for accelerating the clinical translation of nanoparticles
Nature Nanotechnology, 2012, 7, 623-629
23.4662Citations (PDF)
121Engineering of lipid-coated PLGA nanoparticles with a tunable payload of diagnostically active nanocrystals for medical imaging
Chemical Communications, 2012, 48, 5835
2.491Citations (PDF)
122αVβ3 Integrin-Targeted PLGA-PEG Nanoparticles for Enhanced Anti-tumor Efficacy of a Pt(IV) Prodrug
ACS Nano, 2012, 6, 4530-4539
11.5317Citations (PDF)
123Mass Production and Size Control of Lipid–Polymer Hybrid Nanoparticles through Controlled Microvortices
Nano Letters, 2012, 12, 3587-3591
6.2222Citations (PDF)
124Nanoparticle Delivery of Cancer Drugs
Annual Review of Medicine, 2012, 63, 185-198
10.51,502Citations (PDF)
125Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
Chemical Society Reviews, 2012, 41, 2971
32.11,675Citations (PDF)
126Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile
Science Translational Medicine, 2012, 4,
8.71,085Citations (PDF)
127Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo
Proceedings of the National Academy of Sciences of the United States of America, 2011, 108, 1850-1855
5.2504Citations (PDF)
128Self-Assembled Targeted Nanoparticles: Evolution of Technologies and Bench to Bedside Translation
Accounts of Chemical Research, 2011, 44, 1123-1134
11.6467Citations (PDF)
129Advances in Drug Delivery
Annual Review of Materials Research, 2011, 41, 1-20
8.3129Citations (PDF)
130Synthesis of Size‐Tunable Polymeric Nanoparticles Enabled by 3D Hydrodynamic Flow Focusing in Single‐Layer Microchannels
Advanced Materials, 2011, 23,
17.5208Citations (PDF)
131Differentially Charged Hollow Core/Shell Lipid–Polymer–Lipid Hybrid Nanoparticles for Small Interfering RNA Delivery
Angewandte Chemie, 2011, 123, 7165-7169
0.932Citations (PDF)
132Differentially Charged Hollow Core/Shell Lipid–Polymer–Lipid Hybrid Nanoparticles for Small Interfering RNA Delivery
Angewandte Chemie - International Edition, 2011, 50, 7027-7031
11.6181Citations (PDF)
133Effects of ligands with different water solubilities on self-assembly and properties of targeted nanoparticles
Biomaterials, 2011, 32, 6226-6233
9.5179Citations (PDF)
134In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid–polymeric nanoparticles
Proceedings of the National Academy of Sciences of the United States of America, 2011, 108, 19347-19352
5.2138Citations (PDF)
135Emerging Nanotechnology Approaches for HIV/AIDS Treatment and Prevention
Nanomedicine, 2010, 5, 269-285
2.5231Citations (PDF)
136Poly(ethylene glycol) with Observable Shedding
Angewandte Chemie, 2010, 122, 6717-6721
0.99Citations (PDF)
137Poly(ethylene glycol) with Observable Shedding
Angewandte Chemie - International Edition, 2010, 49, 6567-6571
11.669Citations (PDF)
138On firm ground: IP protection of therapeutic nanoparticles
Nature Biotechnology, 2010, 28, 1267-1270
19.779Citations (PDF)
139Spatiotemporal controlled delivery of nanoparticles to injured vasculature
Proceedings of the National Academy of Sciences of the United States of America, 2010, 107, 2213-2218
5.2250Citations (PDF)
140Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy
Proceedings of the National Academy of Sciences of the United States of America, 2010, 107, 17939-17944
5.2564Citations (PDF)
141Chemorad Nanoparticles: A Novel Multifunctional Nanoparticle Platform for Targeted Delivery of Concurrent Chemoradiation
Nanomedicine, 2010, 5, 361-368
2.5103Citations (PDF)
142Single-Step Assembly of Homogenous Lipid−Polymeric and Lipid−Quantum Dot Nanoparticles Enabled by Microfluidic Rapid Mixing
ACS Nano, 2010, 4, 1671-1679
11.5322Citations (PDF)
143pH-Responsive Nanoparticles for Drug Delivery
Molecular Pharmaceutics, 2010, 7, 1913-1920
3.2982Citations (PDF)
144Design of a mechanical clutch-based needle-insertion device
Proceedings of the National Academy of Sciences of the United States of America, 2009, 106, 5540-5545
5.214Citations (PDF)
145PLGA–lecithin–PEG core–shell nanoparticles for controlled drug delivery
Biomaterials, 2009, 30, 1627-1634
9.5674Citations (PDF)
146Immunocompatibility properties of lipid–polymer hybrid nanoparticles with heterogeneous surface functional groups
Biomaterials, 2009, 30, 2231-2240
9.5257Citations (PDF)
147Multifunctional nanoparticles for prostate cancer therapy
Expert Review of Anticancer Therapy, 2009, 9, 211-221
1.523Citations (PDF)
148Superparamagnetic Iron Oxide Nanoparticle–Aptamer Bioconjugates for Combined Prostate Cancer Imaging and Therapy
ChemMedChem, 2008, 3, 1311-1315
2.2314Citations (PDF)
149HER‐2‐Targeted Nanoparticle–Affibody Bioconjugates for Cancer Therapy
ChemMedChem, 2008, 3, 1839-1843
2.2155Citations (PDF)
150The use of charge-coupled polymeric microparticles and micromagnets for modulating the bioavailability of orally delivered macromolecules
Biomaterials, 2008, 29, 1216-1223
9.566Citations (PDF)
151Nanotechnology and aptamers: applications in drug delivery
Trends in Biotechnology, 2008, 26, 442-449
6.6269Citations (PDF)
152New frontiers in nanotechnology for cancer treatment
Urologic Oncology: Seminars and Original Investigations, 2008, 26, 74-85
0.8305Citations (PDF)
153Microfluidic Platform for Controlled Synthesis of Polymeric Nanoparticles
Nano Letters, 2008, 8, 2906-2912
6.2850Citations (PDF)
154Self-Assembled Lipid−Polymer Hybrid Nanoparticles: A Robust Drug Delivery Platform
ACS Nano, 2008, 2, 1696-1702
11.5995Citations (PDF)
155Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles
Molecular Pharmaceutics, 2008, 5, 505-515
3.23,428Citations (PDF)
156Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers
Proceedings of the National Academy of Sciences of the United States of America, 2008, 105, 2586-2591
5.2691Citations (PDF)
157Nanofabrication and Microfabrication of Functional Materials for Tissue Engineering
Tissue Engineering, 2007, 13, 1867-1877
4.8118Citations (PDF)
158Biodegradable, Polymeric Nanoparticle Delivery Systems for Cancer Therapy
Nanomedicine, 2007, 2, 669-680
2.5227Citations (PDF)
159Co-Delivery of Hydrophobic and Hydrophilic Drugs from Nanoparticle–Aptamer Bioconjugates
ChemMedChem, 2007, 2, 1268-1271
2.2258Citations (PDF)
160Targeted nanoparticles for cancer therapy
Nano Today, 2007, 2, 14-21
7.3468Citations (PDF)
161Nanocarriers as an emerging platform for cancer therapy
Nature Nanotechnology, 2007, 2, 751-760
23.48,322Citations (PDF)
162Quantum Dot−Aptamer Conjugates for Synchronous Cancer Imaging, Therapy, and Sensing of Drug Delivery Based on Bi-Fluorescence Resonance Energy Transfer
Nano Letters, 2007, 7, 3065-3070
6.21,008Citations (PDF)
163Formulation of functionalized PLGA–PEG nanoparticles for in vivo targeted drug delivery
Biomaterials, 2007, 28, 869-876
9.51,247Citations (PDF)
164Drug delivery systems in urology—getting “smarter”
Urology, 2006, 68, 463-469
1.131Citations (PDF)
165Micropatterned cell co-cultures using layer-by-layer deposition of extracellular matrix components
Biomaterials, 2006, 27, 1479-1486
9.5224Citations (PDF)
166Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
Proceedings of the National Academy of Sciences of the United States of America, 2006, 103, 6315-6320
5.21,684Citations (PDF)
167Nanoparticle–aptamer bioconjugates for cancer targeting
Expert Opinion on Drug Delivery, 2006, 3, 311-324
3.7259Citations (PDF)
168Magnetically Responsive Polymeric Microparticles for Oral Delivery of Protein Drugs
Pharmaceutical Research, 2006, 23, 557-564
2.5128Citations (PDF)
169An Aptamer–Doxorubicin Physical Conjugate as a Novel Targeted Drug-Delivery Platform
Angewandte Chemie - International Edition, 2006, 45, 8149-8152
11.6596Citations (PDF)
170Microfluidic System for Studying the Interaction of Nanoparticles and Microparticles with Cells
Analytical Chemistry, 2005, 77, 5453-5459
5.2168Citations (PDF)
171Cell docking inside microwells within reversibly sealed microfluidic channels for fabricating multiphenotype cell arrays
Lab on A Chip, 2005, 5, 1380
4.0227Citations (PDF)
172Nanoparticle-Aptamer Bioconjugates
Cancer Research, 2004, 64, 7668-7672
2.6909Citations (PDF)
173CD11c gene expression in hairy cell leukemia is dependent upon activation of the proto-oncogenes ras andjunD
Blood, 2003, 101, 4033-4041
3.644Citations (PDF)
174Regulation of epithelial transport and barrier function by distinct protein kinase C isoforms
American Journal of Physiology - Cell Physiology, 2001, 281, C649-C661
2.983Citations (PDF)
175CD43 gene expression is mediated by a nuclear factor which binds pyrimidine-rich single-stranded DNA
Nucleic Acids Research, 2000, 28, 2256-2267
10.715Citations (PDF)
176Differential effects of PKC isoforms on epithelial transport and barrier function
Gastroenterology, 2000, 118, A609
0.90Citations (PDF)
177Effects of bryostatin 1, a novel anticancer agent, on intestinal transport and barrier function: Role of protein kinase C
Surgery, 1998, 124, 380-387
1.616Citations (PDF)
178Levamisole inhibits intestinal Cl− secretion via basolateral K+ channel blockade
Gastroenterology, 1998, 114, 1257-1267
0.932Citations (PDF)
179Effects of bryostatin 1, a novel anticancer agent, on intestinal transport and barrier function: Role of protein kinase C
Surgery, 1998, 124, 0380-0387
1.60Citations (PDF)
180The Human β2 Integrin CD18 promoter consists of Two Inverted Ets cis Elements
Molecular and Cellular Biology, 1994, 14, 2604-2615
1.524Citations (PDF)